(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol, 95.0%, 5g

(2,2'-Bipyridine)bis[2-(2,4-difluorophenyl)pyridine]iridium(III) Hexafluorophosphate>80.0%(HPLC)200mg

4-Ethyl-3-nitrobenzoic acid, 95.0%, 100g

1-Bromo-4-(cyclohexyloxy)benzene, 97%, 1g

Ethyl 2-(2-aminophenyl)thiazole-4-carboxylate, 95.0%, 100mg

2-((5-Chloroquinolin-8-yl)oxy)-N,N-diethylethanamine dihydrochloride, 98.0%, 250mg

(R)-Benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate, 98%, 100mg

3-Fluoro-4-methoxythiophenol, 95.0%, 5g

4-(4-Chlorobutyl)pyridine hydrochloride, 95.0%, 1g

Methyl 6-bromopyridazine-3-carboxylate, 95.0%, 100g

4-Methyl-5-(4-trifluoromethyl-phenyl)-4H-[1,2,4]triazole-3-thiol, 95.0%, 1g

Ethenesulfonamide, 97%, 5g

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-(tert-butylthio)-D-cysteine, 95+%, 5g